monthly basis. The Respondent did not address these inconsistent findings in his notes
or take appropriate action in view of these inconsistencies.

63. On December 30, 2013, the Respondent ordered UDS that he stated was
"unremarkable." The Respondent did not order any subsequent UDS until July 16,
2014.

64. The Respondent continued to perform lumbar spinal injections in
December 2013 and February 2014, and performed prolotherapy from April through
July 2014. The Respondent continued to prescribe fentanyl patches, hydrocodone,
Soma and temazepam until June 2014, after which he discontinued prescribing fentanyl
patches and hydrocodone. On a visit dated August 18, 2014, the Respondent
prescribed oxycodone 5 mg.

Patient E

65. |The Respondent treated Patient E, a woman in her early-50s, for neck and
arm pain. The Respondent's medical records noted treatment provided from May 2013
through December 2013. During this treatment period, the Respondent performed a
series of peripheral injections and prescribed opioid and non-opioid medications
including OxyContin 20 mg (typically TID), Soma and Topamax.

66. On May 10, 2014, the Respondent ordered UDS that was positive for
methamphetamine. The Respondent did not address this finding in his note.Â°

67. On September 6, 2013, the Respondent ordered UDS that was positive for

cocaine. Patient E's UDS was also positive for methadone and temazepam, neither of

* In a supplemental memorandum, dated May 25, 2015, the Respondent stated that Patient E's positive
methamphetamine finding was "related to her weight loss program under the care of her primary care
physician and not illicit use." The Respondent did not note this in his progress notes, however.

14
